These studies suggest that eIF4E2 can be related to the advancement of carcinoma and that may be an oncogenic protein that significantly overexpressed or upregulated in cancerous tissues, as the same with our research, was screened out as a key biomarker. The gene discussed is EIF4E2; the disease is carcinoma.